research article
Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients
To evaluate the clinical and immunologic outcomes of DC (dendritic cell) vaccine with interleukin (IL)-2 and IFN-alpha 2a in metastatic renal cell carcinoma patients.
Type
research article
Author(s)
Schwaab, Thomas
•
Schwarzer, Adrian
•
•
Crocenzi, Todd S.
•
Seigne, John D.
•
Crosby, Nancy A.
•
Cole, Bernard F.
•
Fisher, Jan L.
•
Uhlenhake, Jill C.
•
Mellinger, Diane
Date Issued
2009
Volume
15
Issue
15
Start page
4986
End page
92
Editorial or Peer reviewed
REVIEWED
Written at
OTHER
EPFL units
Available on Infoscience
November 5, 2012
Use this identifier to reference this record